Tuberculosis: a problem with persistence
暂无分享,去创建一个
[1] M. H. Williams,et al. Treatment of tuberculosis. , 1983, The American review of respiratory disease.
[2] L. Farer,et al. The rising age of the tuberculosis patient: a sign of success and failure. , 1980, The Journal of infectious diseases.
[3] John Chan,et al. Depletion of Cd4+ T Cells Causes Reactivation of Murine Persistent Tuberculosis despite Continued Expression of Interferon γ and Nitric Oxide Synthase 2 , 2000, The Journal of experimental medicine.
[4] S. Vermund,et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. , 1989, The New England journal of medicine.
[5] P. Andersen,et al. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells , 2000, European journal of immunology.
[6] Dirk Schnappinger,et al. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[7] L G Wayne,et al. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions , 1982, Infection and immunity.
[8] D. Crane,et al. Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog , 1996, Journal of bacteriology.
[9] C. Sohaskey,et al. Nonreplicating persistence of mycobacterium tuberculosis. , 2001, Annual review of microbiology.
[10] Christopher J. L. Murray,et al. Tuberculosis: Commentary on a Reemergent Killer , 1992, Science.
[11] Dirk Schnappinger,et al. Inhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy Program , 2003, The Journal of experimental medicine.
[12] I. Orme,et al. In Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice1 , 2002, The Journal of Immunology.
[13] J. Deeks,et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak , 2003, The Lancet.
[14] G. Rook,et al. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection , 2000, The Lancet.
[15] C. Dye,et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.
[16] J. Deeks,et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells , 2001, The Lancet.
[17] W. Jacobs,et al. Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] W. Bishai,et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. , 2001, JAMA.
[19] Alan D. Roberts,et al. Lack of Protection in Mice and Necrotizing Bronchointerstitial Pneumonia with Bronchiolitis in Guinea Pigs Immunized with Vaccines Directed against the hsp60 Molecule ofMycobacterium tuberculosis , 2000, Infection and Immunity.
[20] Tuberculosis. Scientific blueprint for tuberculosis drug development. , 2001, Tuberculosis.
[21] I. Orme,et al. Pulmonary Necrosis Resulting from DNA Vaccination against Tuberculosis , 2003, Infection and Immunity.
[22] G. Kaplan,et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] T. Ganz,et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. , 1998, Science.
[24] A. Dirksen,et al. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. , 2002, The Journal of infectious diseases.
[25] Gerhard Walzl,et al. Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection , 2001, Nature Medicine.
[26] J. Dannenberg. Rabbit Model of Tuberculosis , 1994 .
[27] Tanya Parish,et al. Deletion of Two-Component Regulatory Systems Increases the Virulence of Mycobacterium tuberculosis , 2003, Infection and Immunity.
[28] B. Bloom,et al. Tuberculosis Pathogenesis, Protection, and Control , 1994 .
[29] David L. Cohn. Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection ATS / CDC Statement Committee on Latent Tuberculosis Infection Membership List , June 2000 Co-Chairs , 2015 .
[30] G W Comstock,et al. The prognosis of a positive tuberculin reaction in childhood and adolescence. , 1974, American journal of epidemiology.
[31] D. Smith,et al. Host-parasite relationships in experimental airborne tuberculosis. VII. Fate of Mycobacterium tuberculosis in primary lung lesions and in primary lesion-free lung tissue infected as a result of bacillemia. , 1978, The Journal of infectious diseases.
[32] JoAnne L. Flynn,et al. Effects of Tumor Necrosis Factor Alpha on Host Immune Response in Chronic Persistent Tuberculosis: Possible Role for Limiting Pathology , 2001, Infection and Immunity.
[33] V. Deretic,et al. Effects of cytokines on mycobacterial phagosome maturation. , 1998, Journal of cell science.
[34] James C. Sacchettini,et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase , 2000, Nature.
[35] C. L. Silva,et al. Identification and Characterization of Protective T Cells in hsp65 DNA-Vaccinated and Mycobacterium tuberculosis-Infected Mice , 1998, Infection and Immunity.
[36] Alan D. Roberts,et al. Persistence and Turnover of Antigen-Specific CD4 T Cells During Chronic Tuberculosis Infection in the Mouse 1 , 2003, The Journal of Immunology.
[37] D. Golenbock,et al. Toll-Like Receptor 2-Dependent Inhibition of Macrophage Class II MHC Expression and Antigen Processing by 19-kDa Lipoprotein of Mycobacterium tuberculosis1 , 2001, The Journal of Immunology.
[38] P. Brennan. Foreword from the Co-Editor-in-Chief , 2001 .
[39] Opie,et al. Tubercle Bacilli in Latent Tuberculous Lesions in Lung Tissue without Tuberculous Lesions , 1928 .
[40] D. Mitchison. Treatment of Tuberculosis , 1980, Journal of the Royal College of Physicians of London.
[41] G. Schoolnik,et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. , 1994, The New England journal of medicine.
[42] A. H. Baggenstoss,et al. The residual infectivity of the primary complex of tuberculosis. , 1938, The American journal of pathology.
[43] R. Appelberg,et al. CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis. , 2001, American journal of respiratory cell and molecular biology.
[44] M. Horwitz,et al. The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease , 1996, Nature Medicine.
[45] T. Dick,et al. Analysis of the dormancy-inducible narK2 promoter in Mycobacterium bovis BCG. , 2000, FEMS microbiology letters.
[46] W. Feldman,et al. The occurrence of virulent tubercle bacilli in presumably non-tuberculous lung tissue. , 1939, The American journal of pathology.
[47] A. Khomenko. The variability of Mycobacterium tuberculosis in patients with cavitary pulmonary tuberculosis in the course of chemotherapy. , 1987, Tubercle.
[48] S. Falkow,et al. Complex pattern of Mycobacterium marinum gene expression during long-term granulomatous infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[49] D. Strachan,et al. Molecular epidemiology of tuberculosis in London 1995–7 showing low rate of active transmission , 2002, Thorax.
[50] J. Flynn,et al. Immunology of tuberculosis. , 2003, Annual review of immunology.
[51] J. Wallace. The heat resistance of tubercle bacilli in the lungs of infected mice. , 1961, The American review of respiratory disease.
[52] I. Orme,et al. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[53] R. Johnson,et al. A Novel Role for the Hypoxia Inducible Transcription Factor HIF-1alpha: Critical Regulation of Inflammatory Cell Function , 2003, Cell cycle.
[54] A. Aderem,et al. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[55] Martin Tompa,et al. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis , 2003, Molecular microbiology.
[56] Yu-Jin Jung,et al. Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[57] W. Bishai,et al. Construction and Characterization of aMycobacterium tuberculosis Mutant Lacking the Alternate Sigma Factor Gene, sigF , 2000, Infection and Immunity.
[58] D. Smith,et al. A guinea pig model of experimental airborne tuberculosis for evaluation of the response to chemotherapy: the effect on bacilli in the initial phase of treatment. , 1991, Tubercle.
[59] Y. Belkaid,et al. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.
[60] Joseph Keane,et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent , 2001 .
[61] J. Casanova,et al. Genetic dissection of immunity to mycobacteria: the human model. , 2002, Annual review of immunology.
[62] V. Mizrahi,et al. The Stringent Response of Mycobacterium tuberculosis Is Required for Long-Term Survival , 2000, Journal of bacteriology.
[63] David G. Russell,et al. Mycobacterium tuberculosis: here today, and here tomorrow , 2001, Nature Reviews Molecular Cell Biology.
[64] Robertson He. The Persistence of Tuberculous Infections , 1933 .
[65] N. Reiner,et al. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. , 1998, Journal of immunology.
[66] J. Betts,et al. In Situ Detection of Mycobacterium tuberculosis Transcripts in Human Lung Granulomas Reveals Differential Gene Expression in Necrotic Lesions , 2002, Infection and Immunity.
[67] A. Myers,et al. Non-human primates: a model for tuberculosis research. , 2003, Tuberculosis.
[68] T. Dick,et al. Up-regulation of narX, encoding a putative 'fused nitrate reductase' in anaerobic dormant Mycobacterium bovis BCG. , 1999, FEMS microbiology letters.
[69] Christopher Dye,et al. Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country , 1999 .
[70] R. Rees,et al. Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts. , 1961, British journal of experimental pathology.
[71] D. Snider,et al. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. , 2015, The American review of respiratory disease.
[72] Christopher Dye,et al. Low access to a highly effective therapy: a challenge for international tuberculosis control. , 2002, Bulletin of the World Health Organization.
[73] D B Kell,et al. A bacterial cytokine. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[74] D. McMurray,et al. Disease model: pulmonary tuberculosis. , 2001, Trends in molecular medicine.
[75] D. Smith,et al. Pathogenesis of tuberculosis: pathway to apical localization. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[76] L. Ting,et al. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.
[77] J. Flynn,et al. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. , 1999, Journal of immunology.
[78] V. Deretic,et al. Mycobacterium tuberculosis signal transduction system required for persistent infections , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[79] B. Barrell,et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.
[80] S. Kaufmann,et al. How can immunology contribute to the control of tuberculosis? , 2001, Nature Reviews Immunology.
[81] C. Fritz,et al. Dependence of Mycobacterium bovis BCG on Anaerobic Nitrate Reductase for Persistence Is Tissue Specific , 2002, Infection and Immunity.
[82] N. Federspiel,et al. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. , 2000, Science.
[83] W W Stead,et al. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? , 2015, The American review of respiratory disease.
[84] H. Much. Über die granuläre, nach Ziehl nicht färbbare Form des Tuberkulosevirus , 1907, Beiträge zur Klinik der Tuberkulose und spezifischen Tuberkulose-Forschung.
[85] S. Akira,et al. [Induction of direct antimicrobial activity through mammalian toll-like receptors]. , 2001, Pneumologie.
[86] C. Harding,et al. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. , 1998, Cellular immunology.
[87] T. Geijtenbeek,et al. Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.
[88] P. Schlesinger,et al. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. , 1998, Journal of immunology.
[89] H. Robertson. THE PERSISTENCE OF TUBERCULOUS INFECTIONS , 1934, The American journal of pathology.
[90] E. Pamer,et al. CD8 T cell responses to infectious pathogens. , 2003, Annual review of immunology.
[91] K. Moelling,et al. Therapy of tuberculosis in mice by DNA vaccination , 1999, Nature.
[92] N. Reiner,et al. The 19-kDa Mycobacterium tuberculosis Protein Induces Macrophage Apoptosis Through Toll-Like Receptor-21 , 2003, The Journal of Immunology.
[93] W. Mcdermott,et al. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. , 1966 .
[94] D. Rouse,et al. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. , 1998, The Journal of infectious diseases.
[95] R. Fleischmann,et al. Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative σ factor, SigH , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[96] O. Schwartz,et al. DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells , 2003, The Journal of experimental medicine.
[97] M. Glickman,et al. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. , 2000, Molecular cell.
[98] S. Sakaguchi. Regulatory T cells: mediating compromises between host and parasite , 2003, Nature Immunology.
[99] H. M. Vandiviere,et al. THE TREATED PULMONARY LESION AND ITS TUBERCLE BACILLUS.*: II. THE DEATH AND RESURRECTION , 1956, The American journal of the medical sciences.
[100] J. Flynn,et al. CD8+ CTL from Lungs of Mycobacterium tuberculosis-Infected Mice Express Perforin In Vivo and Lyse Infected Macrophages1 , 2000, The Journal of Immunology.